Drugs - HealthQuill

Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new entity focusing on treating cancers and fibrosis.

Redx, Jounce to merge in a $425 million all-share deal

Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new.

by HealthQuill
February 24, 2023
0 Comments

Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received Breakthrough Therapy Designation from the USFDA.

Drugs Pharma

Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation

Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.

by HealthQuill
February 23, 2023
4 Comments

Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to the WHO.

Drugs Health Pharma

‘Every two minutes, a woman dies during childbirth, pregnancy’

Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to.

by HealthQuill
February 23, 2023
0 Comments

Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.

Drugs Medical Pharma

Merck’s pill fails to prevent COVID-19 infection among households

Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.

by HealthQuill
February 23, 2023
0 Comments

Zydus Lifesciences, a subsidiary of Zydus Pharmaceuticals US, has received two tentative FDA approvals, one for treating type 2 diabetes and the other for shingles.

Drugs Pharma

Zydus gets FDA green light for drugs to treat diabetes, shingles

Zydus Lifesciences, a subsidiary of Zydus Pharmaceuticals US, has received two tentative FDA approvals, one for treating type 2 diabetes and the other.

by HealthQuill
February 20, 2023
1 Comment

Apellis Pharmaceuticals, a US-based biopharmaceutical company, has got FDA approval for a drug to treat geographic atrophy, the company announced.

Drugs Medical Pharma

FDA gives nod for Apellis’ injection to treat geographic atrophy

Apellis Pharmaceuticals, a US-based biopharmaceutical company, has got FDA approval for a drug to treat geographic atrophy, the company announced.

by HealthQuill
February 20, 2023
0 Comments

Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.

Drugs Health Pharma

Embedded LEDs may aid future cancer immunotherapies

Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.

by HealthQuill
February 18, 2023
0 Comments

Glenmark Pharmaceuticals, a US-based company, has received a tentative second FDA approval for its oral drug to treat high blood pressure.

Drugs Pharma

Glenmark gets 2nd FDA nod for high blood sugar drug

Glenmark Pharmaceuticals, a US-based company, has received a tentative second FDA approval for its oral drug to treat high blood pressure.

by HealthQuill
February 17, 2023
0 Comments

GE Healthcare has pulled out 688 medical systems that evaluate diseases, trauma, abnormalities and disorders, a move which USFDA termed a most severe type of recall.

Drugs Medical Pharma

GE Healthcare recalls 688 medical systems, FDA says ‘most serious’

GE Healthcare has pulled out 688 medical systems that evaluate diseases, trauma, abnormalities and disorders, a move which USFDA termed a most severe.